查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621446

干细胞市场：按类型、来源、应用和最终用户划分 - 2025-2030 年全球预测

Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年干细胞市值为136.6亿美元，预计到2024年将达到150.5亿美元，复合年增长率为10.79%，到2030年将达到279.9亿美元。

干细胞是未分化的生物细胞，可以分化成特化细胞并分裂产生更多的干细胞。对干细胞的需求源于它们在再生医学方面的能力，为帕金森氏症、糖尿病和心臟病等多种疾病提供了治疗潜力。其用途广泛，包括医疗、药物发现、研究和开发以及研究目的。调查目标包括医院、诊所、实验室和生技公司。市场成长受到技术进步、研发投资增加以及需要先进医疗解决方案的慢性病盛行率上升的影响。有关干细胞使用的市场开发法规和伦理问题可能对市场成长构成限制和挑战。此外，干细胞治疗的高成本和该领域熟练专业人员的缺乏可能会阻碍市场扩张。然而，在扩大罕见疾病和遗传性疾病的干细胞研究和开发，以及探索与製药公司建立合作伙伴关係以加强药物开发过程方面，存在潜在的机会。创新努力可包括提高干细胞移植的安全性和效率以及开发具有成本效益的生产方法。这个市场充满活力，其特点是快速的技术进步和开创性治疗方法的前景推动了投资者的强烈兴趣。鼓励企业专注于与学术机构和研究公司建立策略联盟，以促进创新。此外，根据不断变化的监管环境调整您的业务策略可以为您带来竞争优势。为了实现永续成长，公司还应优先透过透明度和投资教育大众了解干细胞治疗的好处来解决道德问题。儘管竞争格局仍然充满挑战，但医疗应用和研究领域存在着成长和创新的机会。

主要市场统计
基准年[2023] 136.6亿美元
预测年份 [2024] 150.5亿美元
预测年份 [2030] 279.9亿美元
复合年增长率（%） 10.79%

市场动态：揭示快速发展的干细胞市场的关键市场洞察

供需的动态交互作用正在改变干细胞市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 先进的基因组为基础的细胞分析技术简介
    • 增加对干细胞疗法开发的投资
    • 干细胞库和处理的基础设施开发
  • 市场限制因素
    • 干细胞治疗高成本且缺乏相关技术人员
  • 市场机会
    • iPS 细胞治疗应用的扩展以及利用干细胞进行组织和器官再生的 3D 生物列印的进展
    • 扩大干细胞在个人化医疗的应用
  • 市场挑战
    • 胚胎干细胞研究的伦理问题

波特五力：驾驭干细胞市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解干细胞市场的外部影响

外部宏观环境因素在塑造干细胞市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解干细胞市场的竞争状况

干细胞市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵干细胞市场供应商绩效评估

FPNV定位矩阵是评估干细胞市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议描绘干细胞市场的成功之路

干细胞市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 基于基因组的先进细胞分析技术介绍
      • 增加对干细胞疗法开发的投资
      • 与干细胞储存和处理相关的基础设施开发
    • 抑制因素
      • 干细胞治疗成本高且缺乏熟练的人力资源
    • 机会
      • 扩大 iPSC 的治疗应用以及使用干细胞进行组织和器官再生的 3D 生物列印的进展
      • 扩大干细胞在个人化医疗的应用
    • 任务
      • 胚胎干细胞研究的伦理问题
  • 市场区隔分析
    • 类型：由于道德和监管障碍减少，成体干细胞的使用正在增加
    • 应用：扩大干细胞在诊断模型开发的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章干细胞市场：依类型

  • 成体干细胞
  • 人类胚胎干细胞
  • 诱导性多功能细胞

第七章 干细胞市场：依来源分类

  • 同种异体的
  • 自体移植

第八章干细胞市场：依应用分类

  • 诊断
  • 药物发现与开发
  • 再生医学
    • 心臟病学
    • 神经病学
    • 肿瘤学

第 9 章 干细胞市场：依最终用户分类

  • 学术研究所
  • 医院和细胞库
  • 製药和生物技术公司

第10章美洲干细胞市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区干细胞市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲干细胞市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • QHP Capital 收购 Applied StemCell
    • Stem Genomics 与 Pluristyx 合作提供多功能细胞产品和服务
    • denovoMATRIX 推出首款干细胞产品，扩大产品系列
  • 战略分析和建议

公司名单

  • Advanced Cell Technology, Inc.
  • AlloSource, Inc.
  • Anterogen Co., Ltd.
  • Athersys Inc.
  • Becton, Dickinson and Company
  • Bioheart Inc.
  • Biorestorative Therapies Inc.
  • BioTime, Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Celgene Corporation
  • Cellartis AB
  • CellGenix GmbH
  • Cellular Engineering Technologies Inc.
  • Gamida Cell Ltd
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,
  • JCR Pharmaceuticals Co., Ltd.
  • Lonza Group Ltd
  • Novartis AG
  • NuVasive Inc.
  • Pluristyx, Inc.
  • RTI Surgical
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
Product Code: MRR-434CCDA04CF2

The Stem Cells Market was valued at USD 13.66 billion in 2023, expected to reach USD 15.05 billion in 2024, and is projected to grow at a CAGR of 10.79%, to USD 27.99 billion by 2030.

Stem cells are undifferentiated biological cells capable of differentiating into specialized cells and dividing to produce more stem cells. The necessity of stem cells stems from their capability in regenerative medicine, offering potential treatments for a range of medical conditions such as Parkinson's disease, diabetes, and heart diseases. Their application spans across medical therapies, drug discovery, and development, as well as research purposes. The end-use scope of stem cells includes hospitals, clinics, research centers, and biotechnology companies. Market growth is influenced by technological advancements, increased investments in research and development, and a rising prevalence of chronic diseases that require advanced medical solutions. Developing regulations and ethical concerns regarding stem cell use may pose limitations and challenges to market growth. Furthermore, the high cost of stem cell therapy and lack of skilled professionals in the field can hinder market expansion. Nonetheless, potential opportunities lie in expanding stem cell research and therapy applications to target rare diseases and genetic disorders, as well as exploring partnerships with pharmaceutical companies to enhance drug development processes. Innovations can focus on improving the safety and efficiency of stem cell transplants, and developing cost-effective production methods. The market is dynamic, marked by rapid technological advancement and a keen investor interest driven by the promise of pioneering treatments. Companies are encouraged to focus on strategic alliances with academic institutions and research firms to foster innovations. Additionally, aligning business strategies with evolving regulatory landscapes can provide a competitive advantage. For sustained growth, companies should also prioritize addressing ethical concerns through transparency and investing in educating the public about the benefits of stem cell therapies. The landscape remains competitive, yet rich with opportunities for growth and innovation in medical applications and research avenues.

KEY MARKET STATISTICS
Base Year [2023] USD 13.66 billion
Estimated Year [2024] USD 15.05 billion
Forecast Year [2030] USD 27.99 billion
CAGR (%) 10.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stem Cells Market

The Stem Cells Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Introduction of advanced Genome-based cell analysis techniques
    • Increasing investment in the development of stem cell therapies
    • Infrastructural development related to stem cell banking and processing
  • Market Restraints
    • High costs associated with stem cell therapies and lack of skilled personnel
  • Market Opportunities
    • Expansion of the therapeutic applications of iPSCs and advancements in 3D bioprinting using stem cells for tissue and organ regeneration
    • Growing applications of stem cells in personalized medicine
  • Market Challenges
    • Ethical issues surrounding embryonic stem cell research

Porter's Five Forces: A Strategic Tool for Navigating the Stem Cells Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stem Cells Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stem Cells Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stem Cells Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stem Cells Market

A detailed market share analysis in the Stem Cells Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stem Cells Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stem Cells Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stem Cells Market

A strategic analysis of the Stem Cells Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stem Cells Market, highlighting leading vendors and their innovative profiles. These include Advanced Cell Technology, Inc., AlloSource, Inc., Anterogen Co., Ltd., Athersys Inc., Becton, Dickinson and Company, Bioheart Inc., Biorestorative Therapies Inc., BioTime, Inc., BrainStorm Cell Therapeutics Inc., Celgene Corporation, Cellartis AB, CellGenix GmbH, Cellular Engineering Technologies Inc., Gamida Cell Ltd, GenScript Biotech Corporation, Gilead Sciences, Inc., Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,, JCR Pharmaceuticals Co., Ltd., Lonza Group Ltd, Novartis AG, NuVasive Inc., Pluristyx, Inc., RTI Surgical, Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Adult Stem Cell, Human Embryonic Stem Cell, and Induced Pluripotent Stem Cell.
  • Based on Source, market is studied across Allogenic and Autologous.
  • Based on Application, market is studied across Diagnostics, Drug Discovery & Development, and Regenerative Medicines. The Regenerative Medicines is further studied across Cardiology, Neurology, and Oncology.
  • Based on End-user, market is studied across Academic & Research Institutes, Hospitals & Cell Banks, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Introduction of advanced Genome-based cell analysis techniques
      • 5.1.1.2. Increasing investment in the development of stem cell therapies
      • 5.1.1.3. Infrastructural development related to stem cell banking and processing
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with stem cell therapies and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of the therapeutic applications of iPSCs and advancements in 3D bioprinting using stem cells for tissue and organ regeneration
      • 5.1.3.2. Growing applications of stem cells in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues surrounding embryonic stem cell research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing usage of adult stem cells due to its fewer ethical and regulatory hurdles
    • 5.2.2. Application: Expanding the application of stem cells in developing diagnostic models
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Stem Cells Market, by Type

  • 6.1. Introduction
  • 6.2. Adult Stem Cell
  • 6.3. Human Embryonic Stem Cell
  • 6.4. Induced Pluripotent Stem Cell

7. Stem Cells Market, by Source

  • 7.1. Introduction
  • 7.2. Allogenic
  • 7.3. Autologous

8. Stem Cells Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery & Development
  • 8.4. Regenerative Medicines
    • 8.4.1. Cardiology
    • 8.4.2. Neurology
    • 8.4.3. Oncology

9. Stem Cells Market, by End-user

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Cell Banks
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Stem Cells Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Stem Cells Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Stem Cells Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. QHP Capital Acquires Applied StemCell
    • 13.3.2. Stem Genomics, Pluristyx Partner for Pluripotent Stem Cell Products, Services
    • 13.3.3. denovoMATRIX Expands its Product Portfolio by Launching its First Stem Cell Product
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Cell Technology, Inc.
  • 2. AlloSource, Inc.
  • 3. Anterogen Co., Ltd.
  • 4. Athersys Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bioheart Inc.
  • 7. Biorestorative Therapies Inc.
  • 8. BioTime, Inc.
  • 9. BrainStorm Cell Therapeutics Inc.
  • 10. Celgene Corporation
  • 11. Cellartis AB
  • 12. CellGenix GmbH
  • 13. Cellular Engineering Technologies Inc.
  • 14. Gamida Cell Ltd
  • 15. GenScript Biotech Corporation
  • 16. Gilead Sciences, Inc.
  • 17. Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,
  • 18. JCR Pharmaceuticals Co., Ltd.
  • 19. Lonza Group Ltd
  • 20. Novartis AG
  • 21. NuVasive Inc.
  • 22. Pluristyx, Inc.
  • 23. RTI Surgical
  • 24. Takeda Pharmaceutical Company Limited
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. STEM CELLS MARKET RESEARCH PROCESS
  • FIGURE 2. STEM CELLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STEM CELLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STEM CELLS MARKET DYNAMICS
  • TABLE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STEM CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL STEM CELLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023